Why Physicochemical Characterisation Matters
True efficacy lies in the precise molecular architecture of the liposome. Physicochemical characterization provides a scientific blueprint that proves a formulation has successfully transitioned from a simple physical mixture into an advanced, high-performance liposomal system. Implementing this comprehensive testing protocol ensures that liposomes meet three critical industry standards: optimal biological absorption, flawless batch-to-batch consistency, and maximum shelf life.
Formulation Performance
- Encapsulation Efficiency: It is the percentage of API that is successfully encapsulated inside the liposome. Efficient encapsulation ensures improved bioavailability and therapeutic efficacy. Acceptance criteria >70%
- PDI: Indicates uniformity in the size distribution of liposomes. High uniformity guarantees batch-to-batch clinical consistency. Acceptance criteria: ≤ 0.5
- Particle Size: Nanoscale formulation allows for significantly increased cellular uptake. Acceptance criteria: 200 nm-300 nm
- Zeta Potential: An indicator of the liposome’s surface charge. High Zeta Potential creates a strong repulsion between particles, preventing clumping and ensuring stability. Acceptance criteria: ± 30 mV
Structural & Chemical Confirmation
- FTIR: It acts like a “molecular fingerprint”. Every ingredient has a unique signal. FTIR confirms chemical stability and successful encapsulation of active ingredients into a liposome.
- EDAX: A surface scan using EDAX examines the particle’s surface. Surface scanning verifies the complete absence of actives at the vesicle surface, confirming successful encapsulation.
- SEM: A microscopic-based examination that confirms spherical, smooth-surfaced nanoscale vesicle morphology of liposomes, validating the structural transformation of raw ingredients.
Thermal Stability & Integrity
- Leakage & Stability: Accelerated and real-time protocols monitor structural integrity and moisture resistance at 40°C/75% RH and 30°C/65% RH, respectively, for 6 months.
- DSC: A thermal test that provides molecular proof that the active ingredient is successfully encapsulated inside the liposome rather than just being physically mixed
- TGA: A high-heat stability test that evaluates formulation resistance to severe thermal degradation. TGA quantifies mass loss under extreme heating.
Product-Specific Documentation Includes
Lab reports verifying optimal particle size, size uniformity (PDI ≤ 0.5), surface charge (Zeta Potential ±30 mV), and encapsulation efficiency (>70%) to guarantee product potency.
Absence of original melting peaks confirms robust encapsulation and enhanced thermal protection of active ingredients.
Comprehensive validation data charting formulation integrity over a 6-month period under both real-time (30°C / 65% RH) and accelerated (40°C / 75% RH) environmental conditions.
Technical documentation featuring DSC and TGA thermal analysis to prove successful liposomal encapsulation and robust heat resistance.
Troubleshooting
Low zeta potential, particle clumping, unacceptable PDI variations resolved by optimizing surface charge repulsion
High active presence on vesicle surfaces via EDAX, low encapsulation efficiency below 70%, resolved by modifying lipid-to-active ratio.
Non-spherical morphology/ rough surfaces of liposomes observed via SEM, resolved by adjusting the manufacturing process.
Physical mixing artefacts on DSC, rapid mass loss during high-heat, resolved by adjusting the manufacturing process and/ or lipid-to-active ratio
Readiness
Testing particle size, PDI, surface charge, and encapsulation efficiency to verify baseline vesicle uniformity and stability.
Utilizing FTIR, EDAX, and SEM imaging to chemically and visually confirm successful active ingredient encapsulation over simple physical mixing.
Exposing batches to DSC/TGA thermal scans and 6-month stability chambers under accelerated and real-time conditions to monitor active leakage and product shelf life.
Consolidating performance certificates, stability data, and troubleshooting frameworks into a complete technical package to ensure flawless commercial manufacturing.
Why Collaborate with Lipoedge – Physicochemical
High-precision tracking of particle size, PDI, and Zeta Potential using DLS to guarantee perfect batch uniformity and structural stability.
In-depth structural analysis using FTIR, EDAX, and high-resolution SEM microscopic imaging to visually and chemically confirm successful encapsulation over simple physical mixing.
Application of DSC and TGA thermodynamic analysis alongside 6-month accelerated and real-time stability protocols guarantees robust product shelf life and resistance to leakage under extreme environmental conditions.
Rigorous verification testing to ensure encapsulation efficiency consistently exceeds 70%, proving that the active ingredients are fiercely protected within the lipid bilayer for enhanced bioavailability.
Ready to Elevate Your
Formulation Testing?
Partner with LipoEdge's expert scientific team for end-to-end in vitro analytical support — from study design to regulatory submission.
Frequently Asked Questions
In vitro chemical testing generates release, stability, and bioaccessibility data, enabling informed formulation decisions across nutraceutical, pharmaceutical, and cosmeceutical product development pipelines. This reduces development uncertainty, supports faster optimisation of dosage forms, and strengthens technical confidence before scale-up, validation, and regulatory submission stages.
The INFOGEST model simulates human digestion conditions across salivary, gastric, and intestinal phases, enabling realistic evaluation of liposomal stability and release behaviour. It helps predict oral bioavailability, validate formulation performance under physiological conditions, and support scientifically substantiated claims for product positioning and regulatory documentation.
Dialysis and simulated digestion studies quantify controlled release behaviour, enabling clear differentiation between liposomal systems and conventional formulations in performance-driven markets. This supports claims of sustained delivery, improved absorption, and enhanced functionality, strengthening product positioning across competitive nutraceutical and pharmaceutical segments globally.
LipoEdge provides integrated in vitro testing using validated digestion models, diffusion systems, and antioxidant assays to ensure reliable and reproducible analytical outcomes. It enables clients to generate regulatory-aligned data, optimise formulations effectively, and accelerate product development timelines with strong technical and commercial confidence.
LipoEdge combines formulation understanding with analytical expertise, enabling customised study designs tailored to liposomal, nanosomal, and encapsulated delivery systems across applications. This ensures deeper insight into product behaviour, improved interpretation of results, and stronger alignment between laboratory findings and real-world product performance expectations.